A generic alternative indicated for Mental Health. Precise administration promotes increased comfort by targeting serotonin receptors to assist with persistent anxiety symptoms.
A non-benzodiazepine anxiolytic designed to manage anxiety symptoms and formulated to alleviate tension to support mental health without significant sedation.
Mechanism of Action
It acts as a high-affinity partial agonist at serotonin 5-HT1A receptors. It does not affect GABA receptors, which avoids the typical sedative-hypnotic side effects.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
Requires multiple daily doses
Contraindications
Concurrent use of MAOIs, Severe liver or kidney disease
Information for Buspirone is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
